The U.S. Centers for Disease Control and Prevention (CDC) partnership with the Government of Tajikistan began in 1995 and aims to strengthen the capacity to detect, prevent and control disease and respond to public health threats in Central Asia.
In 2010, CDC began implementing HIV/AIDS activities through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) to strengthen HIV prevention, care, and treatment programs and health system capacities. This includes implementation of evidence-based demonstration programs to identify cost-effective modes of service delivery and expanding prevention and treatment services for key populations.
HIV/AIDS: Partnership with the Ministry of Health’s Republican AIDS Center (RAC) and Republican Narcology Center (RNC) remains critical for achieving epidemic control in Tajikistan. CDC supports the Ministry of Health in the following areas: HIV prevention, including medication-assisted treatment (MAT) of opioid addiction; HIV counseling and testing; laboratory strengthening; HIV care and treatment; and strategic information systems.
Global Health Protection Initiatives: Programs like PEPFAR have helped establish foundational capacity for the public health system and workforce to prevent, detect, and respond to health threats. Other CDC flagship initiatives, such as the Field Epidemiology Training Program (FETP), strengthen the nation’s public health workforce capacity by training public health professionals with the skills to collect disease data, detect outbreaks and mobilize to respond to outbreaks.
In response to the COVID-19 pandemic, CDC supported Tajikistan by leveraging existing public health systems to deliver COVID-19 vaccinations, strengthening systems for laboratory detection of SARS-CoV-2, the virus that causes COVID-19, and providing guidance on reducing the spread of disease in the country and across borders.
The CDC remains committed to supporting the Ministry of Health in Tajikistan and other partners to achieve its public health goals.